文献速递慢性肾脏病急性肾损伤

慢性肾脏病患者尿酸与肾衰竭及死亡风险

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
PubMed 文献 · Am J Kidney Dis · 2017-11-11

该前瞻性观察队列研究纳入3885例CKD 2-4期患者,中位随访7.9年,发现基线尿酸较高与eGFR≥45 mL/min/1.73m²者肾衰竭风险独立相关,但与eGFR<30者无关;尿酸与全因死亡呈J形关系。

要点

  • eGFR≥45的CKD患者中,尿酸每升高1个标准差,肾衰竭风险独立增加40%。
  • 尿酸与全因死亡呈J形关系,提示过低或过高尿酸均可能增加死亡风险。
  • eGFR<30的CKD患者中,尿酸与肾衰竭无独立关联。

核心结论

  • 尿酸是CKD早期阶段肾衰竭的独立危险因素,并与全因死亡呈J形关系。
  • 需足够样本量的随机安慰剂对照试验验证降尿酸能否预防CKD并发症和进展。

研究设计与样本

  • 前瞻性观察性队列研究,纳入2003年6月至2008年9月入组的3885例CKD 2-4期患者,随访至2013年3月。

主要发现

  • 中位随访7.9年,885例进展至肾衰竭,789例死亡。
  • eGFR≥45 mL/min/1.73m²者,基线尿酸每升高1个标准差,肾衰竭调整HR为1.40(95%CI 1.12-1.75)。
  • eGFR 30-44 mL/min/1.73m²者,调整HR为1.13(95%CI 0.99-1.29),未达统计学显著性。
  • eGFR<30 mL/min/1.73m²者,尿酸与肾衰竭无独立关联。
  • 尿酸与全因死亡的关系呈J形(P=0.007)。

临床怎么用

  • 对CKD早期(eGFR≥45)患者,可关注基线尿酸水平以评估肾衰竭风险。
  • 尿酸与死亡呈J形关系,临床管理需避免尿酸过低或过高。

局限性

  • 可能存在未测量混杂因素的残余混杂。
  • 缺乏随访期间尿酸浓度变化的测量,无法校正时间依赖性变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum uric acid concentrations increase in chronic kidney disease (CKD) and may lead to tubular injury, endothelial dysfunction, oxidative stress, and intrarenal inflammation. Whether uric acid concentrations are associated with kidney failure and death in CKD is unknown. STUDY DESIGN: Prospective observational cohort study. SETTINGS & PARTICIPANTS: 3,885 individuals with CKD stages 2 to 4 enrolled in the Chronic Renal Insufficiency Cohort (CRIC) between June 2003 and September 2008 and followed up through March 2013. PREDICTOR: Baseline uric acid concentrations. OUTCOMES: Kidney failure (initiation of dialysis therapy or transplantation) and all-cause mortality. RESULTS: During a median follow-up of 7.9 years, 885 participants progressed to kidney failure and 789 participants died. After adjustment for demographic, cardiovascular, and kidney-specific covariates, higher uric acid concentrations were independently associated with risk for kidney failure in participants with estimated glomerular filtration rates (eGFRs) ≥ 45mL/min/1.73m2 (adjusted HR per 1-standard deviation greater baseline uric acid, 1.40; 95% CI, 1.12-1.75), but not in those with eGFRs<30mL/min/1.73m2. There was a nominally higher HR in participants with eGFRs of 30 to 44mL/min/1.73m2 (adjusted HR, 1.13; 95% CI, 0.99-1.29), but this did not reach statistical significance. The relationship between uric acid concentration and all-cause mortality was J-shaped (P=0.007). LIMITATIONS: Potential residual confounding through unavailable confounders; lack of follow-up measurements to adjust for changes in uric acid concentrations over time. CONCLUSIONS: Uric acid concentration is an independent risk factor for kidney failure in earlier stages of CKD and has a J-shaped relationship with all-cause mortality in CKD. Adequately powered randomized placebo-controlled trials in CKD are needed to test whether urate lowering may prove to be an effective approach to prevent complications and progression of CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Srivastava A, Kaze AD, McMullan CJ, et al. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. Am J Kidney Dis. 2017. PMID: 29132945. doi:10.1053/j.ajkd.2017.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。